Single User
£2450
PDF
26 pages

Hip Fractures and Replacements Forecast for the USA 2016-2026


Hip fractures are defined as a break in the upper quarter of the femur. The extent and exact location of the damage determines the resulting treatment.

Hip fractures most commonly occur in those with low bone mineral density (BMD). While hip fractures can occur at any age, they are most common in those of older age (> 65 years) due to osteoporosis – the most common cause of low BMD.

This report provides the current incidence population for Hip Fractures across the USA split by gender and 5-year age cohort. Along with the current incidence, the report also contains an overview of the risk factors for Hip Fractures, diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main surgical treatments and co-morbidities of Hip Fracture’s have been quantified and presented alongside the overall incidence figures. These sub-populations within the main condition are also included across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Hip Fractures include:

  • Osteoporosis and osteopenia
  • Female
  • Older age

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
  • Able to quantify patient populations in the USA’s Hip Fracture market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Hip Fractures and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for the USA.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Hip Fracture incident population.
  • Identify sub-populations within Hip Fractures which require treatment.
Table of Contents
  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
    • Hip replacements and joint repairs
  • Key Co-morbid Conditions/Features Associated with the Disease
  • Methodology for Quantification of Patient Numbers
  • Top-Line Incidence for Hip Fractures in the USA
  • Location/Type of Hip Fracture
  • Osteoporosis and Other Comorbidities of Hip Fractures
  • Joint Surgery and Replacement for Hip Fractures
    • Transcervical fractures and Joint Repairs
    • Pertrochanteric fractures and Joint Repairs
    • Hip Replacements by ICD Admission Code
  • Utilisation of Health Care Resources for Hip Fractures and Treatment
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
List of Tables
  • Incidence of hip fractures, USA total (000s)
  • Incidence of hip fractures, USA males (000s)
  • Incidence of hip fractures, USA females (000s)
  • 4-digit ICD codes for hip fractures
  • Incidence of hip fractures by 4-digit ICD code, USA (000s)
  • Type of transcervical closed hip fractures, USA (000s)
  • Type of pertrochanteric hip fractures, USA (000s)
  • Osteoporotic patients with incident hip fracture, USA (000s)
  • Osteoporotic patients with incident hip fracture by cause, USA (000s)
  • Incident hip fracture patients with chronic pulmonary disease, USA (000s)
  • Incident hip fracture patients with chronic heart failure, USA (000s)
  • Incident hip fracture patients with cerebrovascular disease, USA (000s)
  • Incident hip fracture patients with chronic renal failure, USA (000s)
  • Incident hip fracture patients with peripheral vascular disease, USA (000s)
  • Incident hip fracture patients with rheumatologic disease, USA (000s)
  • Incident hip fracture patients with chronic liver disease/cirrhosis, USA (000s)
  • ICD codes for joint repair of patients with hip fractures, USA (000s)
  • Patients by type of joint repair for hip fracture, USA (000s)
  • Transcervical fractures (820.0) by main joint repair type, total (000s)
  • Intracapsular fractures (820.00) by main joint repair type, total (000s)
  • Pertrochanteric fractures (820.2) by main joint repair type, total (000s)
  • Intertrochanteric fractures (820.21) by main joint repair type, total (000s)
  • Subtrochanteric fractures (820.22) by main joint repair type, total (000s)
  • Trochanteric fractures (820.20, 820.30) by main joint repair type, total (000s)
  • Total hip replacements by ICD admission code for hip fracture, USA (000s)
  • Partial hip replacements by ICD admission code for hip fracture, USA (000s)
  • Average length of hospital stay (LoS) by ICD admission code for hip fracture, USA (000s)
  • Previous drug treatment received by patients admitted for hip fractures, total (000s)
  • Abbreviations and Acronyms used in the report
List of Figures
  • Possible locations of hip fractures
  • Average LoS for hip fractures by age and gender
  • Distribution of LoS for hip fractures
United States of America